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Background: Insulin-like growth factor 2 (Igf2) is a paternally expressed imprinted gene regulating fetal growth,
playing an integral role in the development of many tissues including the brain. The parent-of-origin specific
expression of Igf2 is largely controlled by allele-specific DNA methylation at CTCF-binding sites in the imprinting
control region (ICR), located immediately upstream of the neighboring H19 gene. Previously we reported evidence
of a negative correlation between DNA methylation in this region and cerebellum weight in humans.
Results: We quantified cerebellar DNA methylation across all four CTCF binding sites spanning the murine Igf2/H19
ICR in an outbred population of Heterogeneous Stock (HS) mice (n = 48). We observe that DNA methylation at the
second and third CTCF binding sites in the Igf2/H19 ICR shows a negative relationship with cerebellar mass,
reflecting the association observed in human post-mortem cerebellum tissue.
Conclusions: Given the important role of the cerebellum in motor control and cognition, and the link between
structural cerebellar abnormalities and neuropsychiatric phenotypes, the identification of epigenetic factors
associated with cerebellum growth and development may provide important insights about the etiology of
psychiatric disorders.
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Genomic imprinting regulates the monoallelic expression
of genes in a parent-of-origin specific manner. To date
>90 imprinted loci have been identified in the mouse
genome [1], many residing in co-regulated clusters with
other imprinted genes, and their allele-specific expression
controls a diverse range of functions including growth
and development [1]. Of note, the imprinted insulin-like
growth factor 2 (Igf2) gene located on mouse distal
chromosome 7, along with other genes in the insulin and
insulin-like growth factor regulatory pathway, has been
shown to be integral for fetal growth and the development
of many tissues including the brain [2-5].* Correspondence: j.mill@exeter.ac.uk
†Equal contributors
1Institute of Psychiatry, King’s College London, De Crespigny Park, Denmark
Hill, London SE5 8AF, UK
2University of Exeter Medical School, University of Exeter, Magdalen Road,
Exeter EX1 2LU, UK
© 2012 Pidsley et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orIn most somatic cells Igf2 and the neighboring H19 gene
are reciprocally imprinted; Igf2 gene expression is silenced
on the maternal allele, whereas H19 is silenced on the
paternal allele. In mice this allele-specific expression is
associated with allele-specific DNA methylation at several
differentially methylated regions (DMRs) in the Igf2 gene
and at the Igf2/H19 imprinting control region (ICR)
located immediately upstream of the H19 promoter [6].
The ICR contains four methylation-sensitive CCCTC-
binding factor (CTCF) binding-sites mediating the as-
sembly of a chromatin insulator that blocks interactions
between the Igf2 promoter and enhancers downstream of
the H19 gene. On the unmethylated maternal allele, CTCF
binds to the ICR silencing Igf2 expression and stimulating
the transcription of H19 (Figure 1). IGF2 is a major driver
of prenatal growth – for example, placenta specific Igf2
transcripts control the growth of the placenta and supply
of maternal nutrients to the developing fetus [7]. IGF2Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Schematic map of the mouse Igf2/H19 locus, with paternal allele (♂) on the top and maternal allele (♀) on the bottom. DMRs
are represented by circles: filled circles indicate a typically methylated allele and empty circles a typically unmethylated allele. In the current study,
DNA methylation was assessed across 5 amplicons spanning the 1st-4th CTCF binding sites of the Igf2/H19 ICR (CTCF1, CTCF2, CTCF3 and CTCF4).
SNPs genotyped are shown as gray triangles (from left to right rs33816033, rs33820807, rs51306385, rs33820056, rs33815374, rs33818240,
rs33816897, rs33816896, rs33815163, rs33818772, rs33817683, rs33816812, rs33818680).
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postnatal growth of somatic tissues including the brain
[5,8]. The H19 gene encodes an untranslated RNA which
acts as a trans-regulator of the imprinted gene network
controlling embryonic growth in mice [9].
Despite being a classically imprinted region, with
clear-cut patterns of allele-specific gene expression, there
is evidence of considerable epigenetic heterogeneity at
the Igf2/H19 locus. Population studies have shown that
DNA methylation across the homologous region in the
human genome is a normally distributed quantitative
trait, which can be influenced by stochastic, genetic and
environmental factors [10,11]. For example, individuals
conceived during famine show alterations in IGF2
methylation [12], whilst polymorphisms in the region
show an independent and additive association with DNA
methylation [10]. Even isogenic strains of mice raised in
a controlled environment demonstrate evidence of epi-
genetic heterogeneity; allelic DNA methylation levels at
the Igf2/H19 locus vary extensively in a tissue-specific
manner during fetal development, primarily on the
expressed paternal allele [13].
The cerebellum is a region of the brain with an im-
portant role in motor control and cognition [14]. The
cerebellum has a protracted period of development [15]
and ultimately accounts for ~12% of total brain weight
[16]. Only a handful of studies have investigated Igf2 ex-
pression and its regulation by genomic imprinting in the
mouse cerebellum. Early work revealed that the Igf2
gene is paternally expressed in cerebellar granule and
glial cells during early postnatal development [17], with
expression being spatially and temporally specific, indi-
cating that the local synthesis of IGF2 is important for
cerebellar development. A recent study showed that Igf2
regulates the proliferation of granule cell precursors,
which ultimately determine the final size and shape of
the cerebellum [18]. Together these results indicate that
the regulation of Igf2 expression during early postnatal
development likely plays an important role in the devel-
opment of the cerebellum.Previously we reported evidence of a strong, negative
correlation between DNA methylation at the IGF2/H19
ICR and cerebellum weight in humans [11]. However,
we observed no relationship between IGF2/H19 DNA
methylation in the frontal cortex and net brain mass,
suggesting that the association is cerebellum-specific. In
the current study we comprehensively quantify cerebel-
lar DNA methylation at all four CTCF binding sites
spanning the murine Igf2/H19 ICR in an outbred popu-
lation of Heterogeneous Stock (HS) mice. We report
that epigenetic variation in the region shows an associ-
ation with between-individual differences in cerebellar
mass, reflecting the association observed in human post-
mortem brain tissue.
Results
Structure of cerebellar DNA methylation across the
murine ICR
Figure 2 shows the correlation between DNA methyla-
tion at all 26 CpG sites spanning the four CTCF binding
sites assessed in this study, using 5 amplicons: CTCF1,
CTCF2, CTCF3, CTCF4_1 and CTCF4_2. Because DNA
methylation is strongly positively correlated between
individual CpG sites within each amplicon, the amplicon-
mean DNA methylation level was used for all subsequent
analyses. DNA methylation was highly correlated be-
tween the two adjacent amplicons covering CTCF4
(CTCF4_1 and CTCF4_2). Interestingly, although DNA
methylation is largely positively correlated across the
amplicons spanning CTCF1, 2 and 3, it is negatively cor-
related between these amplicons and those spanning
CTCF4.
Association of Igf2/H19 DNA methylation with cerebellum
mass
Mean DNA methylation across amplicons CTCF2 and
CTCF3 was significantly lower in the high cerebellar mass
group than the low cerebellar mass group (CTCF2:
t(39) = −1.97, mean high cerebellum mass = 58.1%,
mean low cerebellum mass = 61.9%, p = 0.028; CTCF3:
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Figure 2 Correlation between DNA methylation at individual CpG sites within the mouse Igf2/H19 ICR, assayed using five amplicons
spanning the four CTCF binding sites. CpG sites for each amplicon are numbered according to the CpG sites in Additional file 1: Materials 1.
Two CpG sites have been removed after quality control steps, as described in Additional file 1: Table S2.
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mean low cerebellum mass = 55.9%, p = 0.047) (Figure 3).
Furthermore, cerebellar DNA methylation at CTCF2
and CTCF3 showed a significant negative relationship
with cerebellum mass at both amplicons (CTCF2:
β = −0.35, t(39) = −2.37, p-value = 0.023; CTCF3: β = −0.33,
t(37) = −2.12, p-value = 0.041) (Figure 3). No significant
relationship was observed between DNA methylation
at any other CTCF region and cerebellum mass. Of
note, no association was observed between cerebellar
DNA methylation and net brain mass at either ampli-
con, suggesting that the findings we observe are cere-
bellum-specific. Finally, we tested whether this effect is
specific to DMRs regulating the monoallelic expression
of Igf2 and H19 by quantifying DNA methylation
across DMRs associated with four additional brain-
expressed imprinted genes (Kcnq1ot1, Mcts2, Nap1l5,
and Sgce). No between-group differences in DNAmethylation were observed between animals with high
and low cerebellar mass (Additional file 1: Figure S1).
Multiple linear regression was used to further investigate
the relationship between cerebellar mass and DNA methy-
lation at CTCF2 and CTCF3, including animal batch and
net brain mass as covariates in the analysis. For CTCF2
the overall regression model was significant (adjusted
R-squared = 0.184, F = 4.00 p = 0.015) and explained ap-
proximately 18% of the variance in cerebellum mass, with
DNA methylation (β = −0.31, p = 0.041) and net brain
mass being significantly predictive (β = 0.38, p = 0.031).
The regression model for CTCF3 was also significant
(adjusted R-squared = 0.224, F = 4.65, p = 0.008), explain-
ing approximately 22% of the variance in cerebellum mass,
with DNA methylation (β = −0.36, p = 0.023) and net brain
mass both being predictive (β = 0.48, p = 0.006). Hierarch-
ical linear regression was employed to determine the
unique contribution of net brain mass and DNA
Figure 3 Epigenetic variation at the mouse Igf2/H19 ICR is associated with cerebellum mass. DNA methylation in the cerebellum across
amplicons spanning CTCF2 and CTCF3 is significantly different between mice with high and low cerebellar mass (CTCF2: t(39) = −1.97, p = 0.028;
CTCF3: t(37) = −1.72, p = 0.047). Furthermore, cerebellar DNA methylation at CTCF2 and CTCF3 shows a linear relationship with cerebellum mass
(CTCF2: β = −0.35, p = 0.023; CTCF3: β = −0.33, p = 0.041).
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As expected, net brain weight was significantly associated
with cerebellum weight, explaining 13% of the variance
(R-squared = 0.130, F = 6.993, p = 0.012) for the samples
included in the CTCF2 analysis and 14% of the variance
(R-squared = 0.144, F = 7.374, p = 0.010) for the samples
included in the CTCF3 analysis. DNA methylation,
added in the second step of the analysis, was also a sig-
nificant contributor to the observed variance in cerebel-
lar mass, with CTCF2 methylation explaining 7% of the
variance (ΔR-squared = 0.071, ΔF = −0.944, p = 0.005)
and CTCF3 methylation explaining 8% of the variance
(ΔR-squared = 0.075, ΔF = −1.056, p = 0.004) respectively.
Genetic analyses
In addition to quantifying DNA methylation, we geno-
typed 13 polymorphic single nucleotide polymorphisms
(SNPs) spanning the Igf2 and H19 imprinted gene region
(chr7:149745781–149890507). Standard genetic associ-
ation analyses showed that none of the SNPs tested were
directly associated with total brain mass, cerebellum
mass, or DNA methylation either individually or as
multi-marker haplotypes.
Discussion
These data provide further evidence that epigenetic vari-
ation at the Igf2/H19 ICR is associated with growth and
development of the cerebellum. To our knowledge this
is the first detailed investigation of DNA methylation
across all four CTCF binding sites in the Igf2/H19 ICRin mouse cerebellum. Our results suggest that cerebellar
DNA methylation across the 2nd and 3rd CTCF-binding
sites, upstream of H19, shows a negative relationship
with cerebellum mass, with ~7% of the variance in cere-
bellum mass being uniquely explained by DNA methyla-
tion at these loci. No significant relationship was
observed between DNA methylation and overall net
brain mass for either amplicon, indicating that the effect
of cerebellar DNA methylation at these sites is likely to
be cerebellum-specific. The results from this study con-
cur with our previous data, which highlight a negative
relationship between DNA methylation in the IGF2/H19
ICR in post-mortem human cerebellum tissue and cere-
bellum mass measured at autopsy. Although the human
association was primarily mediated by altered DNA
methylation at the 3rd CTCF binding site, it is hard to
directly compare specific locations across species be-
cause there is incomplete sequence homology between
the mouse and human genome at this region – for ex-
ample the murine ICR contains four CTCF binding sites
whereas the human ICR contains seven.
Epigenetic heterogeneity in the IGF2/H19 ICR is a
normally distributed quantitative trait influenced by sto-
chastic, genetic and environmental factors [19]. We ob-
serve considerably more inter-individual variation at this
locus in human compared to mouse cerebellum, which
may result from the fact that the HS mice used in the
current study were maintained in a controlled laboratory
housing environment and, although outbred, have lim-
ited genetic variation compared to humans. Indeed when
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association with DNA methylation, suggesting that the
reported DNA methylation differences are most likely to
result from stochastic factors, trans-acting genetic fac-
tors, or unmeasured environmental factors. Of note, nu-
trition early in development is associated with decreased
cerebellum mass and alterations to the IGF system
within the cerebellum [20]. Although the HS mice in
this study were given a standard controlled diet, they
may have been exposed to subtle differences in their
rearing – for example, maternal behavior and suckling
prior to weaning – that could also have influenced DNA
methylation.
The mouse cerebellum continues to grow for three
weeks postnatally, at which point its circumference has
reached adult size [21]. Corresponding expression data
suggests that Igf2 mRNA levels are coordinated with
specific growth patterns in the brain [17]. In this study
we have looked at DNA methylation in adult mice to
serve as a proxy for levels of gene expression during de-
velopment. Investigations into the factors determining
cerebellar growth and development are important as a
growing body of work from human and animal studies
suggests that the role of the cerebellum may extend be-
yond the regulation and coordination of motor function,
to attention, perception, working memory and spatial
orientation [14]. In humans, cerebellar abnormalities are
among the most consistently reported structural findings
in autism and attention deficit hyperactivity disorder
[22], and progressive loss of cerebellar volume has been
reported in childhood-onset schizophrenia and other
types of psychosis [23].
The current study has a number of limitations. First,
the absolute mean DNA methylation difference between
the high and low cerebellar groups is relatively modest
(~4%), but is consistent across the multiple adjacent
CpG sites assessed in the CTCF2 and CTCF3 amplicons.
Previous work has shown that Igf2 expression in the
cerebellum is highly cell-type specific [17], and the small
absolute difference we observe may result from much
larger changes in a specific subpopulation of cells. Sec-
ond, although the animals were maintained in a con-
trolled environment, and we were careful to control for
variables such as batch and net brain mass in our ana-
lyses, it is possible that our findings are biased by un-
measured variables or confounding influences such as
maternal behavior. Third, the sodium bisulfite conver-
sion method does not distinguish between methylated
cytosines and hydroxymethylated cytosines, which may
be particularly important here as hydroxymethylation is
relatively enriched in the Purkinje cells of the cerebellum
[24]. Fourth, we did not have access to RNA from the
same samples, so we are unable to relate our epigenetic
data to changes in steady-state mRNA levels. Ourprevious work [11] in humans, however, did not report
an association between altered DNA methylation at this
region and absolute levels of gene expression. It is pos-
sible that the observed DNA methylation changes result
in allelic skewing of expression, rather than changes in
absolute expression values or that DNA methylation
may be a mark of gene expression changes occurring
during development, rather than current gene expres-
sion levels. Fifth, we only analysed DNA methylation in
the cerebellum itself, so we cannot assess the tissue-
specificity of the findings. However, our previous work
in humans looking at several brain regions [11] indicated
that the association between IGF2/H19 DNA methyla-
tion and brain region weight was cerebellum-specific.
Further work would be required to assess the tissue-
specificity of the finding in mouse. Finally, we only
assessed cerebellum mass and DNA methylation at one
time point in adulthood, so could not examine changes
occurring during development.
To conclude, we show that epigenetic variation across
the Igf2/H19 ICR shows a significant negative relation-
ship with cerebellar mass, with hypomethylation at spe-
cific CTCF binding motifs being associated with
increased cerebellar mass, reflecting our previous work
in human tissue. Future work will expand these analyses
to look at brain-region and cell-type specific effects, to
determine the genetic and environmental factors under-
lying the changes in Igf2/H19 DNA methylation and to
explore the relationship between DNA methylation and
gene expression and measures of behavior.
Methods
Animals and brain tissue samples
All housing and experimental procedures were per-
formed in compliance with the UK Home Office Ani-
mals Scientific Procedures Act 1986. Male HS mice were
shipped from the Institute for Behavioral Genetics, Uni-
versity of Colorado at Boulder (Boulder, USA) to the UK
at the age of approximately eight weeks. Mice were indi-
vidually identified upon arrival, and were singly housed
and habituated under strictly controlled housing condi-
tion at the Institute of Psychiatry, King’s College Lon-
don. The animals used in this study had an average age
of 134.4 days (+/− 11.6). Individual animals were
weighed and killed by cervical dislocation. Immediately
after cervical dislocation, the whole brain including ol-
factory bulbs and brainstem was carefully removed from
the skull and placed on the ventral side (dorsal facing
up) on a sterile petri dish containing ice-cold artificial
cerebrospinal fluid over ice. The brains were transected
at the caudal margin of the cerebellum and the olfactory
bulbs dissected out by cutting the fissura rhinalis using a
surgical blade. Wet cerebri (whole brain minus cerebel-
lum and olfactory bulbs) were briefly rolled on filter
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the nearest 0.1 mg (net brain mass). Similarly, the dis-
sected cerebellums were rolled in filter paper and
weighed (cerebellum mass). Tissue samples were snap
frozen on dry ice and stored at −80°C until used for
DNA extraction. Because samples came from three ex-
perimental batches of HS mice, cerebellar mass was
scaled and centered separately by batch. The resulting
distribution was approximately normal with no age ef-
fect, and using these standardized values 48 mice were
selected from a total of 274 from three batches as repre-
senting extremes of cerebellar mass in order to increase
the statistical power to detect an association between
DNA methylation and phenotype [25]. The descriptive
statistics for these animals are given in Table 1.
DNA methylation analysis
DNA was extracted from the cerebellar samples using the
Qiagen AllPrep DNA/RNA Mini Kit (Qiagen, Valencia,
CA, USA) according to the manufacturer’s standard
protocol. Sodium bisulfite conversion of 500 ng genomic
DNA was performed in duplicate using the EZ-96 DNA
Methylation kit (Zymo Research, CA, USA), following the
manufacturer's standard protocol. Bisulfite pyrosequen-
cing was used to quantify DNA methylation at individual
CpG sites within the Igf2 ICR. Primer sequences for 4
amplicons spanning CTCF binding sites 2, 3 and 4 were
acquired from a previously published study [26]. Primers
for CTCF binding site 1 were designed using the Pyro-
Mark Assay Design software 2.0 (Qiagen, UK). Amplicons
are referred to as CTCF1, CTCF2, CTCF3, CTCF4_1 and
CTCF4_2, and their locations can be seen in Figure 1. Pri-
mer sequences for each amplicon are given in Table 2 and
the genomic sequences of each amplicon are given in the
Additional file 1: Materials 1. Bisulfite-PCR amplification
was performed in duplicate using optimized cycling condi-
tions (see Table 2). DNA methylation was quantified using
the Pyromark Q24 system (Qiagen, UK) following the
manufacturer’s standard instructions and the Pyro Q24
CpG 2.0.6 software. DNA methylation across DMRs asso-
ciated with four additional imprinted genes (Kcnq1ot1,Table 1 Uncorrected wet brain and cerebellum mass (mean ±
and b) high and low cerebellum mass
a) n Age (days)
Batch A 13 136.6 ± 3.5 0
Batch B 17 120.1 ± 4.1 0
Batch C 18 145.9 ± 1.1 0
Total 48 134.3 ± 11.6 0
b)
High 24 133.6 ± 12.2 0
Low 24 134.9 ± 11.2 0
Total 48 134.3 ± 11.6 0Mcts2, Nap1l5, and Sgce) was assessed using Sequenom
EpiTYPER as described previously [27]. Assay details are
given in Additional file 1: Table S1.
Statistical analysis
Prior to analysis, stringent data quality control was per-
formed to remove potentially unreliable measurements
of DNA methylation (see Additional file 1: Table S2).
Non-CpG cytosines were used as internal controls to
verify the efficiency of bisulfite conversion. No indica-
tion of incomplete bisulfite conversion was observed for
any sample. All statistical analysis was performed within
the “R” statistical programming environment (http://
www.R-project.org). Spearman’s rank correlation tests
were used to test whether DNA methylation was coordi-
nated within and between the CTCF binding sites. As
CpG sites within each of the amplicons were strongly
and significantly correlated (see Figure 2), mean DNA
methylation scores for the five amplicons were used in
all subsequent analyses. One-sided t-tests were used to
test our hypothesis that high cerebellar mass is asso-
ciated with relative hypomethylation at the Igf2/H19 ICR
CTCF binding sites. Linear regression was subsequently
used to explore any observed association between cere-
bellar mass and DNA methylation. A simple bias correc-
tion method was used to correct for only profiling DNA
methylation in mice with extremes of cerebellar mass
[25]. Multiple linear regression was used to examine
other predictors of cerebellum mass; additional explana-
tory variables in the model were batch and net brain
mass. Hierarchical linear regression models were used to
assess the unique contribution of DNA methylation in
these models. To investigate the specificity of our ana-
lyses to the cerebellum we also used linear regression to
test for an association between net brain mass and cere-
bellar DNA methylation.
Genotype analysis
13 polymorphic SNPs spanning the Igf2/H19 imprinted
region (chr7:149745781–149890507) were selected for
genotype analysis. The SNPs were extracted from existingSD) for the HS mice used in this study, split by a) batch
Cerebellum mass (g) Net brain mass (g)
.072 ± 0.011 0.39 ± 0.03
.071 ± 0.010 0.39 ± 0.02
.067 ± 0.009 0.35 ± 0.02
.070 ± 0.010 0.37 ± 0.03
.079 ± 0.004 0.38 ± 0.02
.060 ± 0.003 0.36 ± 0.02
.070 ± 0.010 0.37 ± 0.03
Table 2 Details of the bisulfite-pyrosequencing DNA methylation assays utilized in this study
Regions Position PCR primers (50 to 30) Annealing
temperature (°C)
Cycle
number
Product length (bp) Sequencing primers
(50 to 30)
CpGs Coordinates in
NCBI37/mm9
CTCF binding site 1 F TTGTTGAATTAGTTGTGGGGTTTA 56 46 149 GAATTAGTTGTGGGGTTTATA 6 chr7:149,767,865-149,768,017
R Biotin-ATTCCAATACCAAAAATAAAAAAACTCT
CTCF binding site 2 F Biotin-AAAGAATTTTTTGTGTGTAAAGATT 56 46 168 AACTCAATCAATTACAATCC 6 chr7:149,767,573-149,767,748
R ATCAAAAACTAACATAAACCCCTAAC
CTCF binding site 3 F GGGTTTTTTTGGTTATTGAATTTTAA 56 46 224 TGTTATGTGTAATAAGGGAA 6 chr7:149,766,533-149,766,776
R Biotin-AATACACACATCTTACCACCCCTATA
CTCF binding site 4 F Biotin-TTTTTGGGTAGTTTTTTTAGTTTTG 56 46 211 CTATAACCAAATCTACACAA 5 chr7:149,766,109-149,766,322
R ACACAAATACCTAATCCCTTTATTAAAC ACTCAAAACTTTATCACAAC 7
Primers for CTCF binding site 1 were designed using PyroMark Assay Design software 2.0 (Qiagen, UK). Primer sequences for all other CTCF binding sites were obtained from a previously published study (Fauque P
et al. Hum Mol Genet. 2010).
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http://www.molecularbrain.com/content/5/1/42microarray data obtained from 40 of the mice included in
this study (20 high and 20 low cerebellum mass). Samples
were genotyped using the Affymetrix Mouse Diversity
Genotyping Array and analysis performed using the
MouseDivGeno package in R (http://cgd.jax.org/tools/
mousedivgeno) [28]. Haploview 4.2 (http://www.broadin-
stitute.org/haploview) was used to establish that all 13
SNPs were in Hardy-Weinberg Equilibrium (HWE).
Lewontin’s D’ and the linkage disequilibrium (LD) coeffi-
cient r2 were calculated using Haploview to measure the
LD between all pairs of biallelic loci. HWE p-values, minor
allele frequencies and LD between the SNPs are given in
Additional file 1: Table S3 and Additional file 1: Figure S2.
ANOVA was used to test each SNP for an association with
total brain mass, cerebellum mass, and mean percentage
cerebellar DNA methylation at each of the five amplicons.
To further interrogate the association between genotype
and DNA methylation we used UNPHASED 3.1.4 (http://
www.mrc-bsu.cam.ac.uk/personal/frank/software/
unphased) to test the association between haplotypes and
mean cerebellum DNA methylation values.Additional file
Additional file 1: Supplementary Materials 1. Genomic sequences of
each amplicon used in this study. Figure S1. No differences in DNA
methylation at four additional imprinted loci (Kcnq1ot1, Mcts2, Nap1l5
and Sgce). Figure S2. High linkage disequilibrium (LD) across the SNPs
genotyped in the murine Igf2/H19 region. Table S1. Details for the
Sequenom EpiTYPER assays used to profile DNA methylation across DMRs
associated with Kcnq1ot1, Mcts2, Nap1l5 and Sgce. Table S2. Stringent
quality control and filtering steps used in analysis of Igf2/H19 DNA
methylation data. Table S3. LD between the SNPs genotyped in Igf2
and H19.Abbreviations
CTCF: CCCTC-binding factor; Igf2: Insulin-like growth factor 2; LD: Linkage
disequilibrium; DNA: deoxyribonucleic acid; RNA: ribonucleic acid;
ICR: imprinting control region; HS: Heterogeneous Stock; PCR: polymerase
chain reaction; DMR: differentially methylated region; SNP: single nucleotide
polymorphism.
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